These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23534743)

  • 1. Exosomes from murine-derived GL26 cells promote glioblastoma tumor growth by reducing number and function of CD8+T cells.
    Liu ZM; Wang YB; Yuan XH
    Asian Pac J Cancer Prev; 2013; 14(1):309-14. PubMed ID: 23534743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells.
    Zhu L; Oh JM; Gangadaran P; Kalimuthu S; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Front Immunol; 2018; 9():824. PubMed ID: 29740437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function.
    Liu C; Yu S; Zinn K; Wang J; Zhang L; Jia Y; Kappes JC; Barnes S; Kimberly RP; Grizzle WE; Zhang HG
    J Immunol; 2006 Feb; 176(3):1375-85. PubMed ID: 16424164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet.
    Lussier DM; Woolf EC; Johnson JL; Brooks KS; Blattman JN; Scheck AC
    BMC Cancer; 2016 May; 16():310. PubMed ID: 27178315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Lymphocyte Subsets in the Immune Response to Primary B Cell-Derived Exosomes.
    Saunderson SC; McLellan AD
    J Immunol; 2017 Oct; 199(7):2225-2235. PubMed ID: 28842467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma.
    Bu N; Wu H; Sun B; Zhang G; Zhan S; Zhang R; Zhou L
    J Neurooncol; 2011 Sep; 104(3):659-67. PubMed ID: 21336773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
    Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
    Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes from CIITA-transfected CT26 cells enhance anti- tumor effects.
    Fan W; Tian XD; Huang E; Zhang JJ
    Asian Pac J Cancer Prev; 2013; 14(2):987-91. PubMed ID: 23621273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different cytokine profiles released by CD4+ and CD8+ tumor-draining lymph node cells involved in mediating tumor regression.
    Aruga A; Aruga E; Cameron MJ; Chang AE
    J Leukoc Biol; 1997 Apr; 61(4):507-16. PubMed ID: 9103238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
    Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
    J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12.
    Kim CH; Hong MJ; Park SD; Kim CK; Park MY; Sohn HJ; Cho HI; Kim TG; Hong YK
    Cancer Immunol Immunother; 2006 Nov; 55(11):1309-19. PubMed ID: 16463038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
    Yin W; Song Y; Liu Q; Wu Y; He R
    Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens.
    Lertmemongkolchai G; Cai G; Hunter CA; Bancroft GJ
    J Immunol; 2001 Jan; 166(2):1097-105. PubMed ID: 11145690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes from Dendritic Cells Loaded with Chaperone-Rich Cell Lysates Elicit a Potent T Cell Immune Response Against Intracranial Glioma in Mice.
    Bu N; Wu H; Zhang G; Zhan S; Zhang R; Sun H; Du Y; Yao L; Wang H
    J Mol Neurosci; 2015 Jul; 56(3):631-43. PubMed ID: 25680514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes.
    Margalit M; Shibolet O; Klein A; Elinav E; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2005 Jun; 115(3):443-9. PubMed ID: 15688366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-7 enhances the in vivo anti-tumor activity of tumor-reactive CD8+ T cells with induction of IFN-gamma in a murine breast cancer model.
    Yuan CH; Yang XQ; Zhu CL; Liu SP; Wang BC; Wang FB
    Asian Pac J Cancer Prev; 2014; 15(1):265-71. PubMed ID: 24528037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
    Xie Y; Bai O; Zhang H; Li W; Xiang J
    Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.
    Sardinha LR; Elias RM; Mosca T; Bastos KR; Marinho CR; D'Império Lima MR; Alvarez JM
    Infect Immun; 2006 Apr; 74(4):2031-42. PubMed ID: 16552032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells.
    Fan D; Li W; Yang Y; Zhang X; Zhang Q; Yan Y; Yang M; Wang J; Xiong D
    J Hematol Oncol; 2015 Oct; 8():108. PubMed ID: 26444983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.